{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:43:16Z","timestamp":1792629796933,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":94,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Natural Science Foundation of Hunan province","award":["2026JJ81247"],"award-info":[{"award-number":["2026JJ81247"]}]},{"name":"Project of Regional Collaborative Innovation Special Program of Lhasa","award":["LSKJ202465"],"award-info":[{"award-number":["LSKJ202465"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61602-7","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:07:12Z","timestamp":1784542032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating transcriptome, metabolome and 16S rRNA sequencing to reveal the effect of celastrol on Alzheimer\u2019s disease in rats"],"prefix":"10.1038","volume":"16","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"1","key":"61602_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-024-00397-x","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. The interaction between ageing and Alzheimer\u2019s disease: Insights from the hallmarks of ageing. Transl. Neurodegener. 13(1), 7 (2024).","journal-title":"Transl. Neurodegener."},{"issue":"7","key":"61602_CR2","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/ijms24076518","volume":"24","author":"B Twarowski","year":"2023","unstructured":"Twarowski, B. & Herbet, M. Inflammatory processes in Alzheimer\u2019s disease-pathomechanism, diagnosis and treatment: A review. Int. J. Mol. Sci. 24(7), 6518 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"61602_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/ijms24010107","volume":"24","author":"AA Rostagno","year":"2022","unstructured":"Rostagno, A. A. Pathogenesis of Alzheimer\u2019s disease. Int. J. Mol. Sci. 24(1), 107 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"61602_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874609814666210302085232","volume":"15","author":"JO Ogbodo","year":"2022","unstructured":"Ogbodo, J. O. et al. Alzheimer\u2019s disease: Pathogenesis and therapeutic interventions. Curr. Aging Sci. 15(1), 2\u201325 (2022).","journal-title":"Curr. Aging Sci."},{"issue":"2","key":"61602_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/ijms24021059","volume":"24","author":"L Piotr","year":"2023","unstructured":"Piotr, L. & Barbara, M. Alzheimer\u2019s disease-biochemical and psychological background for diagnosis and treatment. Int. J. Mol. Sci. 24(2), 1059 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"61602_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","volume":"16","author":"R Briggs","year":"2016","unstructured":"Briggs, R., Kennelly, S. P. & O\u2019Neill, D. Drug treatments in Alzheimer\u2019s disease. Clin. Med. 16(3), 247\u2013253 (2016).","journal-title":"Clin. Med."},{"issue":"22","key":"61602_CR7","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.3390\/ijms232213954","volume":"23","author":"E Passeri","year":"2022","unstructured":"Passeri, E. et al. Alzheimer\u2019s disease: Treatment strategies and their limitations. Int. J. Mol. Sci. 23(22), 13954 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"61602_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3892\/etm.2023.12125","volume":"26","author":"L Tang","year":"2023","unstructured":"Tang, L. et al. LncRNA and circRNA expression profiles in the hippocampus of A\u03b225-35-induced AD mice treated with Tripterygium glycoside. Exp. Ther. Med. 26(3), 426 (2023).","journal-title":"Exp. Ther. Med."},{"key":"61602_CR9","doi-asserted-by":"publisher","first-page":"1444117","DOI":"10.3389\/fphar.2024.1444117","volume":"15","author":"J Xue","year":"2024","unstructured":"Xue, J. et al. Celastrus orbiculatus Thunb. extracts and celastrol alleviate NAFLD by preserving mitochondrial function through activating the FGF21\/AMPK\/PGC-1\u03b1 pathway. Front. Pharmacol. 15, 1444117 (2024).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"61602_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu, H. et al. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. Signal Transduct. Target Ther. 8(1), 51 (2023).","journal-title":"Signal Transduct. Target Ther."},{"issue":"81","key":"61602_CR11","doi-asserted-by":"publisher","first-page":"eadc9324","DOI":"10.1126\/sciimmunol.adc9324","volume":"8","author":"T Shirai","year":"2023","unstructured":"Shirai, T. et al. Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3\/8 complex. Sci. Immunol. 8(81), eadc9324 (2023).","journal-title":"Sci. Immunol."},{"issue":"3","key":"61602_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/toxres\/tfad024","volume":"12","author":"W Peng","year":"2023","unstructured":"Peng, W., Chen, L. & Liu, J. Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1\/CLDN4 axis. Toxicol. Res. 12(3), 392\u2013399 (2023).","journal-title":"Toxicol. Res."},{"key":"61602_CR13","doi-asserted-by":"publisher","first-page":"102615","DOI":"10.1016\/j.pbi.2024.102615","volume":"81","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y., Miettinen, K. & Kampranis, S. C. Celastrol: A century-long journey from the isolation to the biotechnological production and the development of an antiobesity drug. Curr. Opin. Plant Biol. 81, 102615 (2024).","journal-title":"Curr. Opin. Plant Biol."},{"key":"61602_CR14","doi-asserted-by":"publisher","first-page":"114090","DOI":"10.1016\/j.bcp.2020.114090","volume":"178","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Celastrol ameliorates autoimmune disorders in Trex1-deficient mice. Biochem. Pharmacol. 178, 114090 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"61602_CR15","doi-asserted-by":"publisher","first-page":"117121","DOI":"10.1016\/j.biopha.2024.117121","volume":"177","author":"W Tan","year":"2024","unstructured":"Tan, W. et al. Celastrol exerts antiarrhythmic effects in chronic heart failure via NLRP3\/Caspase-1\/IL-1\u03b2 signaling pathway. Biomed. Pharmacother. 177, 117121 (2024).","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"61602_CR16","first-page":"538","volume":"21","author":"F Cao","year":"2024","unstructured":"Cao, F. et al. Celastrol attenuates Alzheimer\u2019s disease-mediated learning and memory impairment by inhibiting endoplasmic reticulum stress-induced inflammation and oxidative stress. Arch. Med. Sci. 21(2), 538\u2013554 (2024).","journal-title":"Arch. Med. Sci."},{"issue":"7","key":"61602_CR17","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0278-5846(01)00192-0","volume":"25","author":"AC Allison","year":"2001","unstructured":"Allison, A. C. et al. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer\u2019s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 25(7), 1341\u20131357 (2001).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"15","key":"61602_CR18","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.3390\/molecules26154700","volume":"26","author":"S Schiavone","year":"2021","unstructured":"Schiavone, S. et al. The therapeutic potential of celastrol in central nervous system disorders: Highlights from in vitro and in vivo approaches. Molecules 26(15), 4700 (2021).","journal-title":"Molecules"},{"key":"61602_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1742-2094-7-17","volume":"7","author":"D Paris","year":"2010","unstructured":"Paris, D. et al. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer\u2019s disease. J. Neuroinflamm. 7, 17 (2010).","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"61602_CR20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3233\/JAD-131799","volume":"41","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y. et al. Celastrol enhances cell viability and inhibits amyloid-\u03b2 production induced by lipopolysaccharide in vitro. J. Alzheimers Dis. 41(3), 835\u2013844 (2014).","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"61602_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11064-025-04375-1","volume":"50","author":"F Cao","year":"2025","unstructured":"Cao, F. et al. Celastrol ameliorated Alzheimer\u2019s disease in mice by enhancing TBX21\/TREM2 expression in microglia and inhibiting tau phosphorylation. Neurochem. Res. 50(2), 126 (2025).","journal-title":"Neurochem. Res."},{"issue":"1","key":"61602_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12967-023-04137-z","volume":"21","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Anti-Alzheimers molecular mechanism of icariin: Insights from gut microbiota, metabolomics, and network pharmacology. J. Transl. Med. 21(1), 277 (2023).","journal-title":"J. Transl. Med."},{"key":"61602_CR23","doi-asserted-by":"publisher","first-page":"1182803","DOI":"10.3389\/fphar.2023.1182803","volume":"14","author":"L Tang","year":"2023","unstructured":"Tang, L. et al. Integrated transcriptome and metabolome analysis to investigate the mechanism of intranasal insulin treatment in a rat model of vascular dementia. Front. Pharmacol. 14, 1182803 (2023).","journal-title":"Front. Pharmacol."},{"key":"61602_CR24","doi-asserted-by":"publisher","first-page":"990307","DOI":"10.3389\/fphar.2022.990307","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an a\u03b225-35-induced rat model of Alzheimer\u2019s disease. Front. Pharmacol. 13, 990307 (2022).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"61602_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13020-023-00745-5","volume":"18","author":"E Hu","year":"2023","unstructured":"Hu, E. et al. A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: The effects of Astragaloside IV on intracerebral hemorrhage as an example. Chin. Med. 18(1), 40 (2023).","journal-title":"Chin. Med."},{"key":"61602_CR26","doi-asserted-by":"publisher","first-page":"897926","DOI":"10.3389\/fphar.2022.897926","volume":"13","author":"Z Zhu","year":"2022","unstructured":"Zhu, Z. et al. Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis. Front. Pharmacol. 13, 897926 (2022).","journal-title":"Front. Pharmacol."},{"key":"61602_CR27","first-page":"7517379","volume":"2021","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Analysis of changes of intestinal flora in elderly patients with Alzheimer\u2019s disease and liver cancer and its correlation with abnormal gastrointestinal motility. J. Oncol. 2021, 7517379 (2021).","journal-title":"J. Oncol."},{"issue":"1","key":"61602_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/gerona\/glaa090","volume":"76","author":"CS Kim","year":"2021","unstructured":"Kim, C. S. et al. Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling older adults: A randomized, double-blind, placebo-controlled, multicenter trial. J. Gerontol. A Biol. Sci. Med. Sci. 76(1), 32\u201340 (2021).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"61602_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbi.2021.09.002","volume":"98","author":"N Kim","year":"2021","unstructured":"Kim, N. et al. Transplantation of gut microbiota derived from Alzheimer\u2019s disease mouse model impairs memory function and neurogenesis in C57BL\/6 mice. Brain Behav. Immun. 98, 357\u2013365 (2021).","journal-title":"Brain Behav. Immun."},{"key":"61602_CR30","doi-asserted-by":"publisher","first-page":"1593854","DOI":"10.3389\/fnins.2025.1593854","volume":"19","author":"C Zhou","year":"2025","unstructured":"Zhou, C. et al. Bidirectional modulation of Alzheimer\u2019s disease via gut microbiota: Rescue by fecal transplantation from healthy donors and aggravation by colitis-associated dysbiosis. Front. Neurosci. 19, 1593854 (2025).","journal-title":"Front. Neurosci."},{"key":"61602_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fphar.2019.00395","volume":"10","author":"H Luo","year":"2019","unstructured":"Luo, H. et al. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway. Front. Pharmacol. 10, 395 (2019).","journal-title":"Front. Pharmacol."},{"key":"61602_CR32","doi-asserted-by":"publisher","first-page":"1117172","DOI":"10.3389\/fimmu.2023.1117172","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. The effects of microglia-associated neuroinflammation on Alzheimer\u2019s disease. Front. Immunol. 14, 1117172 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"61602_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/JLB.3MR1021-531R","volume":"112","author":"E Medrano-Jim\u00e9nez","year":"2022","unstructured":"Medrano-Jim\u00e9nez, E. et al. Microglial activation in Alzheimer\u2019s disease: The role of flavonoids and microRNAs. J. Leukoc. Biol. 112(1), 47\u201377 (2022).","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"61602_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11011-025-01631-9","volume":"40","author":"R Ebrahimi","year":"2025","unstructured":"Ebrahimi, R. et al. Microglial activation as a hallmark of neuroinflammation in Alzheimer\u2019s disease. Metab. Brain Dis. 40(5), 207 (2025).","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"61602_CR35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/ijms24010884","volume":"24","author":"B Sasso","year":"2023","unstructured":"Sasso, B. et al. Microglial activation and priming in Alzheimer\u2019s disease: State of the art and future perspectives. Int. J. Mol. Sci. 24(1), 884 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"61602_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12974-024-03208-2","volume":"21","author":"J Zou","year":"2024","unstructured":"Zou, J. et al. Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by A\u03b21-42 oligomers. J. Neuroinflamm. 21(1), 215 (2024).","journal-title":"J. Neuroinflamm."},{"issue":"12","key":"61602_CR37","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43587-022-00310-z","volume":"2","author":"JB Pereira","year":"2022","unstructured":"Pereira, J. B. et al. Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer\u2019s disease pathology. Nat. Aging 2(12), 1138\u20131144 (2022).","journal-title":"Nat. Aging"},{"issue":"1","key":"61602_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-021-02216-w","volume":"18","author":"DD Liu","year":"2021","unstructured":"Liu, D. D. et al. Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia-reperfusion. J. Neuroinflammation 18(1), 174 (2021).","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"61602_CR39","first-page":"22","volume":"9","author":"P Luo","year":"2022","unstructured":"Luo, P. et al. Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect. Mil. Med. Res. 9(1), 22 (2022).","journal-title":"Mil. Med. Res."},{"issue":"2","key":"61602_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jpha.2022.12.002","volume":"13","author":"Z Hong","year":"2023","unstructured":"Hong, Z. et al. Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke. J. Pharm. Anal. 13(2), 156\u2013169 (2023).","journal-title":"J. Pharm. Anal."},{"issue":"1","key":"61602_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/13880209.2016.1241809","volume":"55","author":"K Veerappan","year":"2017","unstructured":"Veerappan, K. et al. Inhibition of IKK\u03b2 by celastrol and its analogues\u2014An in silico and in vitro approach. Pharm. Biol. 55(1), 368\u2013373 (2017).","journal-title":"Pharm. Biol."},{"issue":"2","key":"61602_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-141899","volume":"46","author":"B Ellis","year":"2015","unstructured":"Ellis, B., Hye, A. & Snowden, S. G. Metabolic modifications in human biofluids suggest the involvement of sphingolipid, antioxidant, and glutamate metabolism in Alzheimer\u2019s disease pathogenesis. J. Alzheimers Dis. 46(2), 313\u2013327 (2015).","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"61602_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12017-010-8121-y","volume":"12","author":"MM Mielke","year":"2010","unstructured":"Mielke, M. M. & Lyketsos, C. G. Alterations of the sphingolipid pathway in Alzheimer\u2019s disease: New biomarkers and treatment targets?. Neuromol. Med. 12(4), 331\u2013340 (2010).","journal-title":"Neuromol. Med."},{"issue":"3","key":"61602_CR44","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3233\/JAD-170735","volume":"60","author":"P Martinez","year":"2017","unstructured":"Martinez, P. & Mielke, M. M. Sphingolipids in Alzheimer\u2019s disease and related disorders. J. Alzheimers Dis. 60(3), 753\u2013756 (2017).","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"61602_CR45","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-160925","volume":"60","author":"MM Mielke","year":"2017","unstructured":"Mielke, M. M. et al. The association between plasma ceramides and sphingomyelins and risk of Alzheimer\u2019s disease differs by sex and APOE in the Baltimore Longitudinal Study of Aging. J. Alzheimers Dis. 60(3), 819\u2013828 (2017).","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"61602_CR46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13195-023-01359-7","volume":"15","author":"XY Chua","year":"2023","unstructured":"Chua, X. Y. et al. Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer\u2019s disease and vascular dementia. Alzheimers Res. Ther. 15(1), 214 (2023).","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"61602_CR47","doi-asserted-by":"publisher","first-page":"2404367","DOI":"10.1080\/17590914.2024.2404367","volume":"16","author":"SM Crivelli","year":"2024","unstructured":"Crivelli, S. M. et al. Abnormal regulation of mitochondrial sphingolipids during aging and Alzheimer\u2019s disease. ASN Neuro 16(1), 2404367 (2024).","journal-title":"ASN Neuro"},{"issue":"7","key":"61602_CR48","doi-asserted-by":"publisher","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","volume":"6","author":"X Han","year":"2011","unstructured":"Han, X. et al. Metabolomics in early Alzheimer\u2019s disease: Identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS ONE 6(7), e21643 (2011).","journal-title":"PLoS ONE"},{"issue":"7\u20138","key":"61602_CR49","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00216-010-4273-8","volume":"398","author":"M Kosicek","year":"2010","unstructured":"Kosicek, M. et al. Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer\u2019s disease patients\u2013a pilot study. Anal. Bioanal. Chem. 398(7\u20138), 2929\u20132937 (2010).","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"61602_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1750-3639.2002.tb00457.x","volume":"12","author":"DR Thai","year":"2002","unstructured":"Thai, D. R. Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer\u2019s disease. Brain Pathol. 12(4), 405\u2013411 (2002).","journal-title":"Brain Pathol."},{"issue":"2","key":"61602_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3233\/JAD-201217","volume":"80","author":"L Piubelli","year":"2021","unstructured":"Piubelli, L. et al. The role of D-amino acids in Alzheimer\u2019s disease. J. Alzheimers Dis. 80(2), 475\u2013492 (2021).","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"61602_CR52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cmet.2020.02.004","volume":"31","author":"J Le Douce","year":"2020","unstructured":"Le Douce, J. et al. Impairment of glycolysis-derived L-serine production in astrocytes contributes to cognitive deficits in Alzheimer\u2019s disease. Cell Metab. 31(3), 503-517.e8 (2020).","journal-title":"Cell Metab."},{"issue":"5","key":"61602_CR53","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1038\/tp.2015.52","volume":"5","author":"C Madeira","year":"2015","unstructured":"Madeira, C. et al. D-serine levels in Alzheimer\u2019s disease: Implications for novel biomarker development. Transl. Psychiatry 5(5), e561 (2015).","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"61602_CR54","doi-asserted-by":"publisher","first-page":"14849","DOI":"10.1038\/s41598-017-13951-7","volume":"7","author":"CH Lin","year":"2017","unstructured":"Lin, C. H. et al. Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging. Sci. Rep. 7(1), 14849 (2017).","journal-title":"Sci. Rep."},{"key":"61602_CR55","doi-asserted-by":"publisher","first-page":"172760","DOI":"10.1016\/j.pbb.2019.172760","volume":"185","author":"CH Lin","year":"2019","unstructured":"Lin, C. H., Yang, H. T. & Lane, H. Y. D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer\u2019s disease or mild cognitive impairment. Pharmacol. Biochem. Behav. 185, 172760 (2019).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"61602_CR56","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.nbd.2019.104511","volume":"130","author":"DT Balu","year":"2019","unstructured":"Balu, D. T. et al. Neurotoxic astrocytes express the D-serine synthesizing enzyme, serine racemase, in Alzheimer\u2019s disease. Neurobiol. Dis. 130, 104511 (2019).","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"61602_CR57","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.3390\/jcm9123840","volume":"9","author":"CH Chang","year":"2020","unstructured":"Chang, C. H. et al. Cerebrospinal fluid and serum d-serine levels in patients with Alzheimer\u2019s disease: A systematic review and meta-analysis. J. Clin. Med. 9(12), 3840 (2020).","journal-title":"J. Clin. Med."},{"key":"61602_CR58","doi-asserted-by":"publisher","first-page":"8988762","DOI":"10.1155\/2021\/8988762","volume":"2021","author":"K Ohno","year":"2021","unstructured":"Ohno, K. et al. GlyCEST: Magnetic resonance imaging of glycine-distribution in the normal murine brain and alterations in 5xFAD mice. Contrast Media Mol. Imaging 2021, 8988762 (2021).","journal-title":"Contrast Media Mol. Imaging"},{"issue":"3","key":"61602_CR59","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00726-021-02943-7","volume":"53","author":"T Nuzzo","year":"2021","unstructured":"Nuzzo, T. et al. High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer\u2019s disease. Amino Acids 53(3), 435\u2013449 (2021).","journal-title":"Amino Acids"},{"issue":"5","key":"61602_CR60","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/nu12051474","volume":"12","author":"F Magne","year":"2020","unstructured":"Magne, F. et al. The Firmicutes\/Bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients?. Nutrients 12(5), 1474 (2020).","journal-title":"Nutrients"},{"issue":"11","key":"61602_CR61","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/microorganisms8111715","volume":"8","author":"S Stojanov","year":"2020","unstructured":"Stojanov, S. et al. The influence of probiotics on the Firmicutes\/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms 8(11), 1715 (2020).","journal-title":"Microorganisms"},{"issue":"9","key":"61602_CR62","first-page":"211244","volume":"68","author":"H Bahar-Tokman","year":"2022","unstructured":"Bahar-Tokman, H. et al. Firmicutes\/Bacteroidetes ratio in the gut microbiota and IL-1\u03b2, IL-6, IL-8, TLR2, TLR4, TLR5 gene expressions in type 2 diabetes. Clin. Lab. 68(9), 211244 (2022).","journal-title":"Clin. Lab."},{"key":"61602_CR63","doi-asserted-by":"publisher","first-page":"634069","DOI":"10.3389\/fcell.2020.634069","volume":"8","author":"Z Ling","year":"2021","unstructured":"Ling, Z. et al. Structural and functional dysbiosis of fecal microbiota in Chinese patients with Alzheimer\u2019s disease. Front Cell Dev Biol. 8, 634069 (2021).","journal-title":"Front Cell Dev Biol."},{"issue":"2","key":"61602_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000526947","volume":"22","author":"P Wanapaisan","year":"2022","unstructured":"Wanapaisan, P. et al. Association between gut microbiota with mild cognitive impairment and Alzheimer\u2019s disease in a Thai population. Neurodegener. Dis. 22(2), 43\u201354 (2022).","journal-title":"Neurodegener. Dis."},{"key":"61602_CR65","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.2147\/NDT.S537129","volume":"21","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Integrated gut microbiota, metabolomics, and network pharmacology to investigate the anti-Alzheimer\u2019s mechanism of tripterygium glycoside. Neuropsych. Dis. Treat. 21, 1911\u20131933 (2025).","journal-title":"Neuropsych. Dis. Treat."},{"issue":"11","key":"61602_CR66","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1111\/cns.14271","volume":"29","author":"W Cui","year":"2023","unstructured":"Cui, W. et al. Changes of gut microbiota in patients at different phases of stroke. CNS Neurosci. Ther. 29(11), 3416\u20133429 (2023).","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"61602_CR67","first-page":"101140","volume":"41","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Preoperative intestinal microbiome and metabolome in elderly patients with delayed neurocognitive recovery. Anaesth. Crit. Care Pain Med. 41(6), 101140 (2022).","journal-title":"Anaesth. Crit. Care Pain Med."},{"issue":"1","key":"61602_CR68","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41531-022-00359-y","volume":"8","author":"P Zhang","year":"2022","unstructured":"Zhang, P. et al. Specific gut microbiota alterations in essential tremor and its difference from Parkinson\u2019s disease. NPJ Parkinsons Dis. 8(1), 98 (2022).","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"61602_CR69","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt, N. M. et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci. Rep. 7(1), 13537 (2017).","journal-title":"Sci. Rep."},{"issue":"2","key":"61602_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/geriatrics10020037","volume":"10","author":"AIC Donaldson","year":"2025","unstructured":"Donaldson, A. I. C. et al. Aging gut-brain interactions: Pro-inflammatory gut bacteria are elevated in fecal samples from individuals living with Alzheimer\u2019s dementia. Geriatrics 10(2), 37 (2025).","journal-title":"Geriatrics"},{"key":"61602_CR71","doi-asserted-by":"publisher","first-page":"e3698","DOI":"10.7717\/peerj.3698","volume":"5","author":"J Gerritsen","year":"2017","unstructured":"Gerritsen, J. et al. Genomic and functional analysis of Romboutsia ilealis CRIBT reveals adaptation to the small intestine. Peer J. 5, e3698 (2017).","journal-title":"Peer J."},{"issue":"2","key":"61602_CR72","doi-asserted-by":"publisher","first-page":"2247025","DOI":"10.1080\/19490976.2023.2247025","volume":"15","author":"X Li","year":"2023","unstructured":"Li, X. et al. Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: A double-blind randomized controlled trial. Gut Microbes 15(2), 2247025 (2023).","journal-title":"Gut Microbes"},{"issue":"4","key":"61602_CR73","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.14336\/AD.2021.1215","volume":"13","author":"XH Qian","year":"2022","unstructured":"Qian, X. H. et al. Mechanisms of short-chain fatty acids derived from gut microbiota in Alzheimer\u2019s disease. Aging Dis. 13(4), 1252\u20131266 (2022).","journal-title":"Aging Dis."},{"key":"61602_CR74","doi-asserted-by":"publisher","first-page":"105694","DOI":"10.1016\/j.phrs.2021.105694","volume":"170","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner. Pharmacol. Res. 170, 105694 (2021).","journal-title":"Pharmacol. Res."},{"key":"61602_CR75","doi-asserted-by":"publisher","first-page":"155385","DOI":"10.1016\/j.phymed.2024.155385","volume":"128","author":"K Cai","year":"2024","unstructured":"Cai, K. et al. Xianlian Jiedu decoction alleviates colorectal cancer by regulating metabolic profiles, intestinal microbiota and metabolites. Phytomedicine 128, 155385 (2024).","journal-title":"Phytomedicine"},{"issue":"11","key":"61602_CR76","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3390\/nu15112507","volume":"15","author":"L Li","year":"2023","unstructured":"Li, L. et al. Calyx extract alleviates glycolipid metabolic disturbance and inflammation by modulating gut microbiota, fecal metabolites, and glycolipid metabolism gene expression in obese mice. Nutrients 15(11), 2507 (2023).","journal-title":"Nutrients"},{"issue":"19","key":"61602_CR77","doi-asserted-by":"publisher","first-page":"e2307556","DOI":"10.1002\/advs.202307556","volume":"11","author":"X Li Sr.","year":"2024","unstructured":"Li, X. Sr. et al. Celastrol ameliorates neuronal mitochondrial dysfunction induced by intracerebral hemorrhage via targeting cAMP-activated exchange protein-1. Adv. Sci. 11(19), e2307556 (2024).","journal-title":"Adv. Sci."},{"issue":"D1","key":"61602_CR78","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61602-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61602-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61602-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:10:40Z","timestamp":1792627840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61602-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61602"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61602-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Changsha Medical University (Ethics Approval Number: D2024008).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"33270"}}